REL and neoplasm: The NF-κB family member c-Rel was utilized in the study, and the use of a small-molecule inhibitor targeting c-Rel led to a notable reduction in the tumor-suppressing capabilities of MDSCs, ultimately resulting in the inhibition of tumor growth (Li et al. 2020).